Published in Shock on November 01, 2006
Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA (2013) 7.23
Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci U S A (2007) 5.36
Hydroxyethyl starches: different products--different effects. Anesthesiology (2009) 3.23
Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology (2013) 3.13
Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med (2007) 2.97
American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res (2007) 2.71
Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol (2002) 2.50
Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation. Proc Natl Acad Sci U S A (2012) 2.28
Effects of combined arginine vasopressin and levosimendan on organ function in ovine septic shock. Crit Care Med (2010) 2.22
Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport. Intensive Care Med (2002) 2.17
Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. Am J Pathol (2008) 2.15
Preclinical evaluation of epinephrine nebulization to reduce airway hyperemia and improve oxygenation after smoke inhalation injury. Crit Care Med (2011) 2.10
Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Crit Care (2012) 2.07
Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol (2005) 2.02
Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents. Crit Care Med (2002) 1.97
Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients. Crit Care Med (2002) 1.96
A novel animal model of sepsis after acute lung injury in sheep. Crit Care Med (2002) 1.95
Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function. Proc Natl Acad Sci U S A (2011) 1.82
Microvascular effects of heart rate control with esmolol in patients with septic shock: a pilot study. Crit Care Med (2013) 1.81
An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. Am J Pathol (2003) 1.80
Synchronized integrin engagement and chemokine activation is crucial in neutrophil extracellular trap-mediated sterile inflammation. Blood (2013) 1.80
Combined burn and smoke inhalation injury impairs ovine hypoxic pulmonary vasoconstriction. Crit Care Med (2006) 1.77
A monobromobimane-based assay to measure the pharmacokinetic profile of reactive sulphide species in blood. Br J Pharmacol (2010) 1.75
The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury. Eur J Cardiothorac Surg (2008) 1.68
Combined neuronal and inducible nitric oxide synthase inhibition in ovine acute lung injury. Crit Care Med (2009) 1.68
Role of selective V1a receptor agonism in ovine septic shock. Crit Care Med (2011) 1.68
Incidence of spinal haematoma after epidural puncture: analysis from the German network for safety in regional anaesthesia. Eur J Anaesthesiol (2012) 1.66
Low-dose terlipressin for hemodynamic support in sepsis and systemic inflammatory response syndrome: art for (he)art's sake or state of the art? Crit Care Med (2005) 1.65
Flagellin from gram-negative bacteria is a potent mediator of acute pulmonary inflammation in sepsis. Shock (2003) 1.64
Therapeutic applications of PARP inhibitors: anticancer therapy and beyond. Mol Aspects Med (2013) 1.62
Management of pulmonary hypertension: physiological and pharmacological considerations for anesthesiologists. Anesth Analg (2003) 1.60
Airway obstruction in sheep with burn and smoke inhalation injuries. Am J Respir Cell Mol Biol (2003) 1.58
FGF23 signaling impairs neutrophil recruitment and host defense during CKD. J Clin Invest (2016) 1.57
Inhibition of neuronal nitric oxide synthase in ovine model of acute lung injury. Crit Care Med (2009) 1.57
Selectivity of commonly used pharmacological inhibitors for cystathionine β synthase (CBS) and cystathionine γ lyase (CSE). Br J Pharmacol (2013) 1.56
Continuous terlipressin infusion in patients with septic shock: less may be best, and the earlier the better? Intensive Care Med (2007) 1.55
Single-lung ventilation for pulmonary lobe resection in a newborn. Anesth Analg (2005) 1.55
Continuous nebulized albuterol attenuates acute lung injury in an ovine model of combined burn and smoke inhalation. Crit Care Med (2006) 1.52
Role of nitric oxide in acute lung inflammation: lessons learned from the inducible nitric oxide synthase knockout mouse. Crit Care Med (2002) 1.51
Anti-inflammatory adjuvant in resuscitation fluids improves survival in hemorrhage. Crit Care Med (2009) 1.51
Reversible cardiac sympathectomy by high thoracic epidural anesthesia improves regional left ventricular function in patients undergoing coronary artery bypass grafting: a randomized trial. Arch Surg (2003) 1.50
Therapeutic administration of thoracic epidural anesthesia reduces cardiopulmonary deterioration in ovine pulmonary embolism. Crit Care Med (2007) 1.49
Arterial blood pressure during early sepsis and outcome. Intensive Care Med (2009) 1.49
Cardiopulmonary effects of low-dose arginine vasopressin in ovine acute lung injury. Crit Care Med (2011) 1.47
Inhaled nitric oxide reduces lung edema during fluid resuscitation in ovine acute lung injury. Intensive Care Med (2003) 1.47
Effects of balanced crystalloid vs. 0.9% saline-based vs. balanced 6% tetrastarch infusion on renal function and tubular integrity in ovine endotoxemic shock. Crit Care Med (2011) 1.46
Identification of conserved domains in Salmonella muenchen flagellin that are essential for its ability to activate TLR5 and to induce an inflammatory response in vitro. J Biol Chem (2003) 1.46
Parenteral administration of glipizide sodium salt, an inhibitor of adenosine triphosphate-sensitive potassium channels, prolongs short-term survival after severe controlled hemorrhage in rats. Crit Care Med (2003) 1.46
Early multiple organ failure after recurrent endotoxemia in the presence of vasoconstrictor-masked hypovolemia. Crit Care Med (2003) 1.46
Cerebral response to norepinephrine compared with fluid resuscitation in ovine traumatic brain injury and systemic inflammation. Crit Care Med (2006) 1.45
Delayed onset of malignant hyperthermia in desflurane anesthesia. Anesth Analg (2003) 1.44
Unlike arginine vasopressin, the selective V1a receptor agonist FE 202158 does not cause procoagulant effects by releasing von Willebrand factor. Crit Care Med (2012) 1.44
Therapeutic injection of PARP inhibitor INO-1001 preserves cardiac function in porcine myocardial ischemia and reperfusion without reducing infarct size. Shock (2010) 1.44
Intramitochondrial hydrogen sulfide production by 3-mercaptopyruvate sulfurtransferase maintains mitochondrial electron flow and supports cellular bioenergetics. FASEB J (2012) 1.44
Beneficial effects of concomitant neuronal and inducible nitric oxide synthase inhibition in ovine burn and inhalation injury. Shock (2011) 1.42
A tribute to Dr. Paul A. J. Janssen: entrepreneur extraordinaire, innovative scientist, and significant contributor to anesthesiology. Anesth Analg (2008) 1.41
Intensive care medicine: a multidisciplinary approach! Eur J Anaesthesiol (2011) 1.40
Nebulized nitric oxide/nucleophile adduct reduces pulmonary vascular resistance in mechanically ventilated septicemic sheep. Crit Care Med (2005) 1.40
Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology. Eur J Anaesthesiol (2010) 1.37
Postoperative analgesia after knee surgery: a comparison of three different concentrations of ropivacaine for continuous femoral nerve blockade. Anesth Analg (2007) 1.32
Effect of poly(ADP ribose) synthetase inhibition on burn and smoke inhalation injury in sheep. Am J Physiol Lung Cell Mol Physiol (2003) 1.32
Protective effect of a novel, potent inhibitor of poly(adenosine 5'-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis. Crit Care Med (2002) 1.32
Upper airway mucus deposition in lung tissue of burn trauma victims. Shock (2008) 1.30
Heparin nebulization attenuates acute lung injury in sepsis following smoke inhalation in sheep. Shock (2002) 1.30
Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury. J Thorac Cardiovasc Surg (2009) 1.27
Protective effect of hydrogen sulfide in a murine model of acute lung injury induced by combined burn and smoke inhalation. Clin Sci (Lond) (2008) 1.27
Levosimendan for resuscitating the microcirculation in patients with septic shock: a randomized controlled study. Crit Care (2010) 1.26
Pathophysiology of acute lung injury in combined burn and smoke inhalation injury. Clin Sci (Lond) (2004) 1.26
Pathophysiological basis of smoke inhalation injury. News Physiol Sci (2003) 1.25
Re-evaluating currently available data and suggestions for planning randomised controlled studies regarding the use of hydroxyethyl starch in critically ill patients - a multidisciplinary statement. Crit Care (2013) 1.24
Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft. Mol Cancer Ther (2005) 1.23
Alpha7 cholinergic-agonist prevents systemic inflammation and improves survival during resuscitation. J Cell Mol Med (2008) 1.22
Recombinant human activated protein C improves pulmonary function in ovine acute lung injury resulting from smoke inhalation and sepsis. Crit Care Med (2006) 1.20
Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Crit Care (2009) 1.20